Busulfan test dose: Clinical Trials

3 trials of Busulfan test dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 3

Follow Busulfan test dose: new trials by email Literature Review of Busulfan test dose trials Research Report on Busulfan test dose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Allogeneic HSCT, Busulfan test dose, Mycophenolate mofetil (MMF) - Immunodeficiency, Hematopoietic Stem Cell Transplantation
Phase 2RecruitingNational Cancer Institute (NCI)542023-02-232026-10-16
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Busulfan test dose, Fludarabine, Busulfan - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative
Phase 2RecruitingNational Cancer Institute (NCI)662020-09-222026-11-12
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Allogeneic HSCT, Busulfan Test dose, Fludarabine (Fludara, Berlex Laboratories) - GATA2, Immunodeficiency
Phase 2RecruitingNational Cancer Institute (NCI)1442013-07-242026-10-16

Conditions studied

Autoimmune Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Common Variable Immunodeficiency (1)  ·  Immune System Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Myelodysplastic Syndromes (1)  ·  Opportunistic Infections (1)  ·  T cell immunodeficiency primary (1)

Sponsors

National Cancer Institute (NCI) (3)

Countries

United States (3)

Top investigators

Bhavisha A Patel, M.D. (1)  ·  Danielle E Pregent-Arnold, M.D. (1)  ·  Sung-Yun Pai, M.D. (1)

Results publications

PMID 32556286, PMID 36251488, PMID 37595058, PMID 41175032, PMID 41370196